Cargando…
20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report
BACKGROUND: We developed a simple and new insulin resistance index derived from a glucose clamp and a meal tolerance test (MTT) in Japanese patients with type 2 diabetes mellitus. METHODS: Fifteen patients [mean age: 53 years, fasting plasma glucose (FPG) 7.7 mmol/L, HbA1c 7.1% (54 mmol/mol), body m...
Autores principales: | Ohkura, Tsuyoshi, Shiochi, Hideki, Fujioka, Youhei, Sumi, Keisuke, Yamamoto, Naoya, Matsuzawa, Kazuhiko, Izawa, Shoichiro, Kinoshita, Hiroshi, Ohkura, Hiroko, Kato, Masahiko, Taniguchi, Shin-ichi, Yamamoto, Kazuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608161/ https://www.ncbi.nlm.nih.gov/pubmed/23339473 http://dx.doi.org/10.1186/1475-2840-12-21 |
Ejemplares similares
-
Sitagliptin Improves the Impaired Acute Insulin Response during a Meal Tolerance Test in Japanese Patients with Type 2 Diabetes Mellitus: A Small-Scale Real-World Study
por: Ohkura, Tsuyoshi, et al.
Publicado: (2014) -
The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical study
por: Ohkura, Tsuyoshi, et al.
Publicado: (2013) -
Low serum galectin-3 concentrations are associated with insulin resistance in patients with type 2 diabetes mellitus
por: Ohkura, Tsuyoshi, et al.
Publicado: (2014) -
Bezafibrate improves insulin resistance evaluated using the glucose clamp technique in patients with type 2 diabetes mellitus: a small-scale clinical study
por: Shiochi, Hideki, et al.
Publicado: (2014) -
Normal meal tolerance test is preferable to the glucagon stimulation test in patients with type 2 diabetes that are not in a hyperglycemic state: Comparison with the change of C‐peptide immunoreactivity
por: Fujioka, Youhei, et al.
Publicado: (2017)